Invention Grant
- Patent Title: Antibody therapeutics that bind CD123
-
Application No.: US16135886Application Date: 2018-09-19
-
Publication No.: US10934361B2Publication Date: 2021-03-02
- Inventor: Heyue Zhou , John Dixon Gray
- Applicant: Sorrento Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Sorrento Therapeutics, Inc.
- Current Assignee: Sorrento Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Baker Botts L.L.P.
- Main IPC: C07K16/28
- IPC: C07K16/28

Abstract:
There is disclosed compositions and methods relating to or derived from anti-CD123 antibodies. More specifically, there is disclosed fully human antibodies that bind CD123, CD123-antibody binding fragments and derivatives of such antibodies, and CD123-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
Public/Granted literature
- US20190002576A1 ANTIBODY THERAPEUTICS THAT BIND CD123 Public/Granted day:2019-01-03
Information query